Mast Cell

WASHINGTON — Urticaria activity symptom scores improved with barzolvolimab among patients with chronic spontaneous urticaria, according to a presentation at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

The pro-inflammatory protein IL-3 appeared to regulate the burden of allergic asthma by inducing T regulatory cell response and reducing the proliferation of type 2 innate lymphoid cells, according to a study in Frontiers in Immunology.

Omalizumab may effectively treat idiopathic anaphylaxis in patients without indication of mast cell clonality and who have failed on prior treatments, according to study results published in Annals of Allergy, Asthma & Immunology.

Food Allergy Research & Education has awarded a $500,000 grant to a research project seeking to find new biomarkers for food allergies, according to an organization press release.